Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Koenen AM"'
Autor:
Embaby A; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands. Electronic address: a.embaby@nki.nl., Heinhuis KM; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., IJzerman NS; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Clinical Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Koenen AM; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., van der Kleij S; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Hofland I; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., van Boven H; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands., van der Graaf WTA; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands., Haas RL; Department of Radiotherapy, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands; Department of Pharmacology, Princess Màxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., van Houdt WJ; Department of Surgical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 May; Vol. 202, pp. 113974. Date of Electronic Publication: 2024 Mar 02.
Autor:
van der Burg SJC; Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., van de Wal D; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., Roets E; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands.; Dutch Sarcoma Group, Dutch GIST Consortium, Utrecht, The Netherlands., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands.; Dutch Sarcoma Group, Dutch GIST Consortium, Utrecht, The Netherlands., van Sandick JW; Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., Kerst M; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., van Coevorden F; Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., Hartemink KJ; Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., Veenhof XAAFA; Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., Koenen AM; Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., Ijzerman N; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands., Schrage YM; Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands.; Dutch Sarcoma Group, Dutch GIST Consortium, Utrecht, The Netherlands., van Houdt WJ; Department of Surgery, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital (NCI-AVL), Amsterdam, The Netherlands. w.v.houdt@nki.nl.
Publikováno v:
Annals of surgical oncology [Ann Surg Oncol] 2023 Dec; Vol. 30 (13), pp. 8660-8668. Date of Electronic Publication: 2023 Oct 09.
Autor:
van Meekeren M; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Bovee JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., van Coevorden F; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Houdt W; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Schrage Y; Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Koenen AM; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Miah AB; Department of Clinical Oncology, The Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom., Zaidi S; Department of Clinical Oncology, The Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom., Hayes AJ; Department of Surgery, The Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom., Thway K; Department of Pathology, The Royal Marsden Hospital and The Institute of Cancer Research, London, United Kingdom., Krol S; Department of Radiotherapy, Leiden University Medical Center, Leiden, the Netherlands., Fiocco M; Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, the Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Haas RL; Department of Radiotherapy, Leiden University Medical Center, Leiden, the Netherlands.; Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2021 Dec; Vol. 60 (12), pp. 1557-1564. Date of Electronic Publication: 2021 Sep 23.
Autor:
Heinhuis KM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands., IJzerman NS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands n.ijzerman@nki.nl.; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Koenen AM; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Graaf WTA; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., Haas RL; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., van Houdt WJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Steeghs N; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
BMJ open [BMJ Open] 2020 Sep 10; Vol. 10 (9), pp. e039449. Date of Electronic Publication: 2020 Sep 10.
Autor:
IJzerman NS; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; Erasmus MC - Cancer Institute, Department of Medical Oncology, Dr. Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands. Electronic address: n.ijzerman@nki.nl., Groenland SL; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Koenen AM; Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Kerst M; Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., van der Graaf WTA; Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; Department of Pharmaceutical Sciences, Utrecht University, Heidelberglaan 8, 3584 CS, Utrecht, the Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands; Department of Clinical Pharmacy, University Medical Center, Utrecht University, Heidelberglaan 8, 3584 CS, Utrecht, the Netherlands., Steeghs N; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Sep; Vol. 136, pp. 140-148. Date of Electronic Publication: 2020 Jul 17.
Autor:
Rozeman EA; The Netherlands Cancer Institute, Amsterdam, Netherlands., Menzies AM; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., van Akkooi ACJ; The Netherlands Cancer Institute, Amsterdam, Netherlands., Adhikari C; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia., Bierman C; The Netherlands Cancer Institute, Amsterdam, Netherlands., van de Wiel BA; The Netherlands Cancer Institute, Amsterdam, Netherlands., Scolyer RA; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Krijgsman O; The Netherlands Cancer Institute, Amsterdam, Netherlands., Sikorska K; The Netherlands Cancer Institute, Amsterdam, Netherlands., Eriksson H; Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden., Broeks A; The Netherlands Cancer Institute, Amsterdam, Netherlands., van Thienen JV; The Netherlands Cancer Institute, Amsterdam, Netherlands., Guminski AD; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Acosta AT; The Netherlands Cancer Institute, Amsterdam, Netherlands., Ter Meulen S; The Netherlands Cancer Institute, Amsterdam, Netherlands., Koenen AM; The Netherlands Cancer Institute, Amsterdam, Netherlands., Bosch LJW; The Netherlands Cancer Institute, Amsterdam, Netherlands., Shannon K; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Pronk LM; The Netherlands Cancer Institute, Amsterdam, Netherlands., Gonzalez M; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia., Ch'ng S; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Grijpink-Ongering LG; The Netherlands Cancer Institute, Amsterdam, Netherlands., Stretch J; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Heijmink S; The Netherlands Cancer Institute, Amsterdam, Netherlands., van Tinteren H; The Netherlands Cancer Institute, Amsterdam, Netherlands., Haanen JBAG; The Netherlands Cancer Institute, Amsterdam, Netherlands., Nieweg OE; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., Klop WMC; The Netherlands Cancer Institute, Amsterdam, Netherlands., Zuur CL; The Netherlands Cancer Institute, Amsterdam, Netherlands., Saw RPM; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia., van Houdt WJ; The Netherlands Cancer Institute, Amsterdam, Netherlands., Peeper DS; The Netherlands Cancer Institute, Amsterdam, Netherlands., Spillane AJ; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Hansson J; Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden., Schumacher TN; The Netherlands Cancer Institute, Amsterdam, Netherlands., Long GV; Melanoma Institute of Australia, The University of Sydney, Sydney, NSW, Australia., Blank CU; The Netherlands Cancer Institute, Amsterdam, Netherlands. Electronic address: c.blank@nki.nl.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2019 Jul; Vol. 20 (7), pp. 948-960. Date of Electronic Publication: 2019 May 31.
Autor:
Vlenterie M; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands myrella.vlenterie@radboudumc.nl., Oyen WJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands., Steeghs N; Department of Medical Oncology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands., Desar IME; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Verheijen RB; Department of Pharmacy, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands., Koenen AM; Department of Medical Oncology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands., Grootjans W; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands., DE Geus-Oei LF; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands., VAN Erp NP; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands., VAN DER Graaf WT; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Medical Oncology, Antoni van Leeuwenhoek - Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
Anticancer research [Anticancer Res] 2019 Mar; Vol. 39 (3), pp. 1309-1316.